申请人:INTITUTE OF PHARMACOLOGY AND TOXICOLOGY ACADEMY OF MILITARY MEDICAL SCIENCES P.L.A. CHINA
公开号:US20150126500A1
公开(公告)日:2015-05-07
Provided are piperazinyl pyrimidine derivatives of formula I having CCR
4
antagonism, and the preparation method, pharmaceutical composition and use thereof in the preparation of a medicament. The medicament is useful for the treatment and prevention of CCR
4
-related diseases.
提供了具有CCR4拮抗作用的式I的哌嗪基嘧啶衍生物,以及其制备方法、药物组合物及在制备药物中的用途。该药物用于治疗和预防与CCR4相关的疾病。